In Patients With COVID-19, Fluvoxamine May Be Associated With Lower Risk Of Clinical Deterioration, Study Suggests
December 07, 2020
Healio (12/4, N. Dreisbach) reported, “Use of the antidepressant fluvoxamine in patients with COVID-19 was associated with a slightly lower likelihood of clinical deterioration over 15 days in a small study, according to results published in JAMA.” In the...